Filing Flows › 908 Devices (MASS) › Q1 2026 › vs Q4 2025
908 Devices (MASS) Q1 2026 vs Q4 2025 (quarter over quarter)
908 Devices's revenue fell $4.0M (-23%) from $17.4M in Q4 2025 to $13.4M in Q1 2026. The biggest changes: Device sales revenue −$2.5M (-21%); Recurring revenue −$1.5M (-27%).
908 Devices, Q1 2026: revenue $13.4M (+14% year over year), operating margin -96.3%, net loss $12.0M, operating cash flow $1.2M. The chart draws each line against Q4 2025, the increases inside each band.
Margins
| Q1 2026 | Q4 2025 | Change | |
|---|---|---|---|
| Free cash flow margin | 8.7% | 7.6% | +1.1 pts |
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Device sales revenue | $9.4M | $11.9M | −$2.5M | -21% |
| Recurring revenue | $4.0M | $5.5M | −$1.5M | -27% |
| Revenue | $13.4M | $17.4M | −$4.0M | -23% |
| Other income, net | $929K | $916K | $13K | +1% |
| Net loss | $12.0M | −$4.2M | $16.1M | — |
| Costs & expenses | $26.3M | $18.5M | $7.8M | +42% |
| Operating costs | $26.3M | $14.3M | $12.0M | +84% |
| Cost of revenue | $6.5M | $8.2M | −$1.7M | -21% |
| Operating cash sources | $13.2M | −$2.9M | $16.0M | — |
| Depreciation & amortization | $1.1M | $1.1M | $28K | +3% |
| Share-based compensation | $2.4M | $2.8M | −$366K | -13% |
| Working capital & other | $9.6M | −$6.7M | $16.4M | — |
| Net loss absorbed | $12.0M | −$4.2M | $16.1M | — |
| Operating cash flow | $1.2M | $1.3M | −$114K | -9% |
| Free cash flow (OCF − capex) | $1.2M | $1.3M | −$160K | -12% |
| Capital expenditures | $40K | −$6K | $46K | — |
Questions
How much did 908 Devices's revenue grow quarter over quarter in Q1 2026?
908 Devices's revenue fell $4.0M (-23%) from $17.4M in Q4 2025 to $13.4M in Q1 2026.
What drove 908 Devices's revenue change in Q1 2026?
Device sales revenue −$2.5M (-21%); Recurring revenue −$1.5M (-27%).